Taiwan · Delayed Price · Currency is TWD G&E Herbal Biotechnology Statistics
Total Valuation
TPEX:4911 has a market cap or net worth of TWD 1.85 billion. The enterprise value is 1.43 billion.
| Market Cap | 1.85B |
| Enterprise Value | 1.43B |
Important Dates
The next estimated earnings date is Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Jul 28, 2026 |
Share Statistics
TPEX:4911 has 63.72 million shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 63.72M |
| Shares Outstanding | 63.72M |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +3.88% |
| Owned by Insiders (%) | 25.32% |
| Owned by Institutions (%) | n/a |
| Float | 47.59M |
Valuation Ratios
The trailing PE ratio is 23.25.
| PE Ratio | 23.25 |
| Forward PE | n/a |
| PS Ratio | 8.59 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 2.49 |
| P/FCF Ratio | 102.20 |
| P/OCF Ratio | 87.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.23, with an EV/FCF ratio of 78.71.
| EV / Earnings | 16.53 |
| EV / Sales | 6.61 |
| EV / EBITDA | 15.23 |
| EV / EBIT | 17.19 |
| EV / FCF | 78.71 |
Financial Position
The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.69 |
| Quick Ratio | 4.37 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | 0.02 |
| Interest Coverage | 4,145.80 |
Financial Efficiency
Return on equity (ROE) is 9.91% and return on invested capital (ROIC) is 16.47%.
| Return on Equity (ROE) | 9.91% |
| Return on Assets (ROA) | 5.21% |
| Return on Invested Capital (ROIC) | 16.47% |
| Return on Capital Employed (ROCE) | 9.46% |
| Weighted Average Cost of Capital (WACC) | 0.25% |
| Revenue Per Employee | 5.01M |
| Profits Per Employee | 2.01M |
| Employee Count | 43 |
| Asset Turnover | 0.22 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, TPEX:4911 has paid 3.01 million in taxes.
| Income Tax | 3.01M |
| Effective Tax Rate | 3.37% |
Stock Price Statistics
The stock price has decreased by -35.71% in the last 52 weeks. The beta is -0.73, so TPEX:4911's price volatility has been lower than the market average.
| Beta (5Y) | -0.73 |
| 52-Week Price Change | -35.71% |
| 50-Day Moving Average | 29.74 |
| 200-Day Moving Average | 34.92 |
| Relative Strength Index (RSI) | 48.69 |
| Average Volume (20 Days) | 36,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4911 had revenue of TWD 215.61 million and earned 86.25 million in profits. Earnings per share was 1.25.
| Revenue | 215.61M |
| Gross Profit | 173.54M |
| Operating Income | 82.92M |
| Pretax Income | 89.26M |
| Net Income | 86.25M |
| EBITDA | 92.72M |
| EBIT | 82.92M |
| Earnings Per Share (EPS) | 1.25 |
Balance Sheet
The company has 425.82 million in cash and 423,000 in debt, with a net cash position of 425.40 million or 6.68 per share.
| Cash & Cash Equivalents | 425.82M |
| Total Debt | 423,000 |
| Net Cash | 425.40M |
| Net Cash Per Share | 6.68 |
| Equity (Book Value) | 876.54M |
| Book Value Per Share | 12.74 |
| Working Capital | 371.55M |
Cash Flow
In the last 12 months, operating cash flow was 21.07 million and capital expenditures -2.96 million, giving a free cash flow of 18.11 million.
| Operating Cash Flow | 21.07M |
| Capital Expenditures | -2.96M |
| Depreciation & Amortization | 9.80M |
| Net Borrowing | -887,000 |
| Free Cash Flow | 18.11M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 80.49%, with operating and profit margins of 38.46% and 40.00%.
| Gross Margin | 80.49% |
| Operating Margin | 38.46% |
| Pretax Margin | 41.40% |
| Profit Margin | 40.00% |
| EBITDA Margin | 43.00% |
| EBIT Margin | 38.46% |
| FCF Margin | 8.40% |
Dividends & Yields
This stock pays an annual dividend of 1.08, which amounts to a dividend yield of 3.88%.
| Dividend Per Share | 1.08 |
| Dividend Yield | 3.88% |
| Dividend Growth (YoY) | 66.38% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 51.78% |
| Buyback Yield | -0.17% |
| Shareholder Yield | 3.71% |
| Earnings Yield | 4.66% |
| FCF Yield | 0.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 28, 2026. It was a forward split with a ratio of 1.079999993.
| Last Split Date | Jul 28, 2026 |
| Split Type | Forward |
| Split Ratio | 1.079999993 |
Scores
TPEX:4911 has an Altman Z-Score of 16.91 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.91 |
| Piotroski F-Score | 4 |